Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-03-29 4:23 pm Purchase | 2022-03-24 | 13G | Sierra Oncology, Inc. SRRA | Frazier Life Sciences Public Fund, L.P. | 2,366,853 10.000% | 1,562,186![]() (+194.14%) | Filing |
2021-08-16 4:17 pm Purchase | 2021-08-06 | 13G | Sierra Oncology, Inc. SRRA | Frazier Life Sciences Public Fund, L.P. | 804,667 9.500% | 804,667![]() (New Position) | Filing |